(NASDAQ: AFFX) and PathGEN Dx Pte. Ltd., a spin-off molecular diagnostics company founded by researchers from the Genome Institute of Singapore, today announced they have signed a agreement. Under ...
ROCKVILLE, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (MXCT),, a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results